Table 5.

Influence of LRYGB vs. LSG group on OR of secondary endpoints

Event	OR	95% CI	p	Test power, %
Intraoperative adverse events	1.78	0.78–4.03	0.169	40.88%
Postoperative complications	1.22	0.65–2.28	0.536	12.25%
Clavien-Dindo I–II	0.86	0.38–1.95	0.720	7.41%
Clavien-Dindo III–V	1.99	0.76–5.25	0.163	42.04%
Biochemical rhabdomyolysis	4.15	1.06–16.22	0.040	73.11%
Gastrointestinal leakage	0.87	1.57–4.77	0.868	5.56%
Gastrointestinal stricture	0.49	0.10–2.38	0.377	20.01%
Postoperative hemorrhage	2.34	0.52–10.54	0.270	28.55%
Wound infection	1.74	0.11–27.92	0.697	8.09%
Pneumonia	3.51	0.64–19.35	0.149	28.55%
Reoperations	1.39	0.37–5.25	0.623	9.52%